UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act 1934
Date of Report (Date of earliest event reported): September 4, 2012
Coronado Biosciences, Inc.
(Exact name of registrant as specified in charter)
| | | | |
| Delaware | | 001-35366 | | 20-5157386 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| |
15 New England Executive Park, Burlington, MA | | 01803 |
| (Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (781) 238-6621
(Former Name or Former Address, is Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01. Regulation FD Disclosures.
On September 5, 2012, executives of Coronado Biosciences, Inc. (the “Company”) will make a presentation about the Company to certain analysts and investors at the Stifel Niclolaus 2012 Healthcare Conference in Boston, Massachusetts. A copy of the slide presentation is furnished as exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
| | |
Exhibit
No. | | Description |
| |
| 99.1 | | September 5, 2012 Slide Presentation |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, we have duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | |
| | | | CORONADO BIOSCIENCES, INC. |
| | | |
| | | | By: | | /s/ Lucy Lu |
| | | | | | Name: Lucy Lu |
| | | | | | Title: Chief Financial Officer |
Dated: September 4, 2012
EXHIBIT INDEX
| | |
Exhibit
No. | | Description |
| |
| 99.1 | | September 5, 2012 Slide Presentation |
